Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1997-10-15
2000-01-25
Ceperley, Mary E.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
4284022, A61K 9127
Patent
active
060175575
ABSTRACT:
Lipid-based carriers are provided herein that have a lamellar lipid component composed of an etherlipid and a complementarily shaped lipid. This novel combination of lipids allows for the incorporation of etherlipids in the carriers at higher concentrations than would otherwise be possible. Pharmaceutical compositions containing the carriers can be used therapeutically, for example, in the treatment of cancers.
REFERENCES:
patent: 3752886 (1973-08-01), Munder et al.
patent: 4426525 (1984-01-01), Hozumi et al.
patent: 4734225 (1988-03-01), Eibl
patent: 4804789 (1989-02-01), Eibl
patent: 4965391 (1990-10-01), Counsell et al.
patent: 4983397 (1991-01-01), Schroit et al.
patent: 5077057 (1991-12-01), Szoka et al.
patent: 5169637 (1992-12-01), Lenk et al.
Bazill, et al., "Role of Endocytosis in the Action of Eher Lipids on WEHI-3B, HL60, and FDCP-Mix A4 Cells", Cancer REsearch, 50, 7505-7512, Dec. 1, 1990.
Berdel, "Ether Lipids and Derivatives as Investigational Anticancer Drugs", Onkologie 1990: 13:245-250.
Bhatia, et al., "Stereospecific Synthesis of Antitumor Active Thioether PAF Analogs", Lipids, 26(12), 1424-1430, 1991.
Chen, et al., "Microdetermination of Phosphorus", Anal. Chem., 28 (110), 1756-1758; 1956.
Deamer, et al., "Liposome Preparation: Methods and Mechansims", in Liposomes, Marcel Dekker, ed. M. Ostro, 1983, 27-51.
Dietzfelbinger, et al., "Removal of Breast Cancer Cells from Bone Marow by in Vitro Purging with Ether Lipids and Cryopreservation", Cancer Research 53, 3747-3751, Aug. 15, 1993.
Gruner, "Nonlamellar Lipis Phases", in The Structure of Biological Membranes, 1992, CRC Press, ed. P. Yeagle, Buffalo, NY, pp. 222-223.
Kumar, et al., "Phosphlipid Deitribution and Headgroup Motion in Phosphatidylcholine Liposomes of Different Size", Biophys. J., 53, 1988, 121a.
Layton, et al., "The Interaction of Liposomes with Cells: The Relation of Cell Specific Toxicity to Lipid Composition", Eur J Cancer, 16, 1529-1538, 1980.
Madden, et al., "Stabilization of bilayer Structure for Unsaturated Phosphatidylethanolamines by Detergents", BBA, 684(1982), 149-153.
Nairn, et al., "Solutions, Emulsions, Suspensions and Extractives", in Pharmaceutical Sciences, 1985, Mack Publishing Co., Easton, PA.
Papahadjopoulos, et al. "Phospholipid Model Membranes, I. Structural Characteristics of Hydrated Liquid Crystals", BBA 135 (1967) 624-638.
Powis, et al., "Selective Inhibition of Phosphatidyloinositol Phospholipase C by Cytotoxic Ether Lipid Analogues", Cancer Research 52, 2835-2840, May 15, 1992.
Reed, et al., "Antineoplastic Ether-Linked Phospholipid Inudces Differentiation of Acute Myelogenous Leukemic KG-1 Cells Into Macrophase-Like Cells", Life Sciences, 49, 1221-1227, 1991.
Runge, "Destruction of human Solid tumors by Alkyl Lysophospholipids", JNCI, 64(6), Jun. 1980, 1301-1306.
Tritton, et al., "How to Kill Cancer Cells: Membranes and Cell signaling as Targets in Cancer Chemotherapy", Cancer Cells, Apr. 1990, 95-105.
Stedman's Medical Dictionary, pp. 707-708.
Stedman's Medical Dictionary, pp. 123-124.
Workman, "Antitumor Ether Lipids: Endocytosis as a Determinant of Cellular Sensitivity", Cancer Cells, 3(8), 315-317, Aug. 1991.
Workman, et al., "Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-Methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells", Biochemical Pharmacology, 41(2), 319-322, 1991.
Wu, et al., "Modified In Vivo behavior of Liposomes Containing Synthetic Glycolipids", BBA 674 (1981), 19-29.
Zeisig, et al., "Antineoplastic activity in vitro of free an liposomal alkylphosphocholines", Anti-Cancer Drugs, 4, 57-64, 1993.
Franklin J. Craig
Janoff Andrew
Mayhew Eric
Perkins Walter
Ceperley Mary E.
Goodman Rosanne
The Liposome Company Inc.
LandOfFree
Carriers containing an etherlipid/complementarily shape lipid co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carriers containing an etherlipid/complementarily shape lipid co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carriers containing an etherlipid/complementarily shape lipid co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2314117